Stay updated on Risankizumab in Ulcerative Colitis Clinical Trial
Sign up to get notified when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.

Latest updates to the Risankizumab in Ulcerative Colitis Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe page history shows an addition of Revision: v3.4.2 and deletion of Revision: v3.4.1. This is metadata about versioning and does not modify study data or user-visible content.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.4.1 was added and Revision: v3.4.0 was removed from the history.SummaryDifference0.0%

- Check41 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4 on the Record History page for NCT03398148.SummaryDifference0.0%

- Check62 days agoChange DetectedRevision: v3.3.3 was added and the HHS Vulnerability Disclosure and Revision: v3.3.2 were removed, these are administrative footer updates. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check91 days agoChange DetectedThe Record History now includes an added revision entry for v3.3.2 and removes the v3.2.0 entry. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check99 days agoChange DetectedThe page no longer displays the government funding and NIH operating status notice. This change does not affect the clinical trial data or submission process.SummaryDifference0.2%

Stay in the know with updates to Risankizumab in Ulcerative Colitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Risankizumab in Ulcerative Colitis Clinical Trial page.